28 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 May 24
Maravai Lifesciences Reports First Quarter 2024 Financial Results
4:09pm
and Scientific Innovation
SAN DIEGO, Calif., — May 8, 2024 — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life … and Innovation:
TriLink BioTechnologies and Lonza entered into a Non-exclusive License and Supply Agreement for CleanCap® M6, CleanCap® AG 3’OMe, CleanCap®
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 May 23
Maravai Lifesciences Reports First Quarter 2023 Financial Results
4:09pm
and Scientific Innovation
SAN DIEGO, Calif., — May 8, 2023 — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life … , Executive Chairman and Interim CEO of Maravai. “Our culture of innovation, combined with our strong commercial foundation and expanded manufacturing
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
20 Jul 23
Maravai LifeSciences Announces Appointment of New Director to the Board
4:08pm
of the Board of the Medical Device Innovation Consortium (MDIC) and stepped down from the Board in anticipation of the increased time commitment
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
7 Aug 23
Maravai Lifesciences Reports Second Quarter 2023 Financial Results
4:19pm
and Scientific Innovation
SAN DIEGO, Calif., — August 7, 2023 — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider … .”
Martin added “At Maravai, our team is determined to meet our customers’ needs through product innovation and value-added service expertise to help
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
22 Feb 24
Maravai Lifesciences Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
, Market Leadership and Innovation
SAN DIEGO, Calif., — February 22, 2024 — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider … million.
Product Innovation, Partnerships and Awards:
TriLink BioTechnologies® awarded Patents for CleanCap® technology in China and Canada, re
8-K
EX-99.1
huic4df6x80
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
8-K
EX-99.1
m14r9rs4
10 Nov 21
Maravai Lifesciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance for 2022
4:09pm
8-K
EX-99.1
m8yspaeh1 kv
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
8-K
EX-99.1
pv6f8ozhrt
7 Nov 23
Maravai Lifesciences Reports Third Quarter 2023 Financial Results
4:11pm
424B4
t8q8lawyvy9 tq
23 Nov 20
Prospectus supplement with pricing info
4:36pm
DRS/A
sjrifk08giqd 5kxji87
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
ln1wn
14 Oct 20
Draft registration statement (amended)
12:00am
S-1
j8p54
29 Oct 20
IPO registration
5:04pm
DRS
lw66ad878gdwe24
8 Sep 20
Draft registration statement
12:00am
10-K
nz12rk yg9uy317oyz5d
22 Mar 21
Annual report
4:22pm
10-Q
ijru u8zg
12 May 21
Quarterly report
4:26pm